Aura Biosciences, Inc.
AURA
$7.00
$0.142.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -33.69M | -25.56M | -26.13M | -27.02M | -27.48M |
| Total Depreciation and Amortization | 274.00K | 272.00K | 280.00K | 286.00K | 291.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.94M | 3.26M | 3.74M | 3.93M | 3.41M |
| Change in Net Operating Assets | -426.00K | 1.56M | 1.96M | 2.03M | 423.00K |
| Cash from Operations | -29.89M | -20.47M | -20.14M | -20.77M | -23.36M |
| Capital Expenditure | -102.00K | -176.00K | -45.00K | -39.00K | -187.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.00M | 30.00M | -43.97M | 20.02M | 30.00M |
| Cash from Investing | 54.90M | 29.82M | -44.02M | 19.98M | 29.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 177.00K | 2.77M | 4.36M | 46.52M | 96.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 123.00K | 0.00 | 0.00 | 23.41M | -- |
| Cash from Financing | 300.00K | 2.77M | 4.36M | 69.93M | 96.00K |
| Foreign Exchange rate Adjustments | -27.00K | -160.00K | -14.00K | 9.00K | -21.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.28M | 11.96M | -59.81M | 69.14M | 6.53M |